Caricamento...
EpCAM expression in esophageal cancer and its correlation with immunotherapy of solitomab
BACKGROUND: Recurrence of esophageal cancer (EC) after chemotherapy may mainly be explained by the existence of chemotherapy-resistant cells, and an effective drug against chemotherapy-resistant cells is highly sought. The aim of this study was to investigate the cytotoxicity of bispecific antibody...
Salvato in:
| Pubblicato in: | J Thorac Dis |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
AME Publishing Company
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8107559/ https://ncbi.nlm.nih.gov/pubmed/34012588 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd-21-442 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|